Deploying NGS into Clinic Practice: A Practical Guide for Navigating Regulatory Hurdles and Commercialization

Martin Siaw, Vice President of Science and Innovation

Dr. Martin Siaw is currently Vice President of Science and Innovation at BRIDGenomics, LLC. He also serves a similar role at BasePrime Genomics, LLC. His previous positions include Global Director of Clinical Operations at LabPMM, LLC and Associate Scientific Director of Advanced Sequencing at Quest Diagnostics. He has many years of laboratory experience and technical expertise in assay development for the biotechnology and medical diagnostics industry. He was the technical co-lead for the development of the first NGS based test for HIV-1 Tropism that is being offered by Quest. He is focused on advancing the use of NGS for molecular diagnostic testing geared towards improving health care and wellness.